1. Home
  2. KPTI vs PGP Comparison

KPTI vs PGP Comparison

Compare KPTI & PGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$5.57

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Logo Pimco Global StocksPlus & Income Fund of Beneficial Interest

PGP

Pimco Global StocksPlus & Income Fund of Beneficial Interest

HOLD

Current Price

$8.33

Market Cap

102.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPTI
PGP
Founded
2008
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.6M
102.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
KPTI
PGP
Price
$5.57
$8.33
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.2M
46.9K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
10.84%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$46.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$3.51
$6.56
52 Week High
$10.99
$9.41

Technical Indicators

Market Signals
Indicator
KPTI
PGP
Relative Strength Index (RSI) 32.41 38.98
Support Level $3.93 $8.03
Resistance Level $6.82 $8.37
Average True Range (ATR) 0.83 0.21
MACD -0.31 -0.01
Stochastic Oscillator 13.24 40.44

Price Performance

Historical Comparison
KPTI
PGP

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest

PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, and long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.

Share on Social Networks: